On Friday, Depomed Inc (NASDAQ:DEPO)’s shares inclined 2.29% to $21.89.
Depomed Inc (DEPO) declared it has reached a settlement agreement in its ongoing patent litigation related to an Abbreviated New Drug Application (ANDA) seeking approval to market a generic version of Depomed’s Zipsor® (diclofenac liquid filled capsules) 25mg tablets. The settlement permits defendant Watson Laboratories Inc. to start selling generic Zipsor on March 24, 2022, or earlier under certain circumstances. The settlement concludes all ongoing ANDA litigation related to Zipsor.
The settlement agreement is subject to review by the U.S. Department of Justice and the Federal Trade Commission, and entry of an order dismissing the litigation by the U.S. District Court for the District of New Jersey.
Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the administration of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults.
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)’s shares dropped -1.52% to $0.650.
Oncolytics Biotech, Inc. (USA) (ONCY) declared that its 2015 Annual Meeting of Shareholders will be held on Monday June 8th, 2015 at 2:30 pm CT (3:30 pm ET) at the Wyndham Grand Chicago Riverfront, 71 East Upper Wacker Drive, Chicago, Illinois.
Following the business portion of the meeting, Dr. Brad Thompson, President and CEO of Oncolytics, will talk about recent progress in the development of REOLYSIN® as a potential cancer therapeutic.
A live audio webcast of the presentation will start at about 3:00 pm CT (4:00 pm ET).
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a cancer therapeutic that is in various clinical trials for human use.
At the end of Friday’s trade, Intuit Inc. (NASDAQ:INTU)‘s shares surged 0.13% to $105.60.
Intuit Inc. (INTU) declared that QuickBooks Online has more than 1 million paying subscribers, cementing its market leadership as small businesses shift to the cloud.
Intuit has served small businesses and accountants with QuickBooks for more than 20 years. The company was an early innovator in cloud accounting when it first launched QuickBooks Online in 2001. Recently, small business owners are turning to the cloud in record numbers. Intuit research shows that:
- S. small businesses presently spend an average of four hours per day running their business online. Their top three tasks: accounting, generating invoices and taking payments, and engaging their customers.
- Seventy-eight percent of small businesses will run their business online by 2020.
- QuickBooks Online growth mirrors these trends, posting eight successive quarters of accelerating growth, counting noteworthy expansion outside the U.S.
Intuit Inc. provides business and financial administration solutions for small businesses, consumers, and accounting professionals in the United States, Canada, the United Kingdom, Australia, India, and Singapore. The company’s Small Business segment provides QuickBooks financial and business administration online services and desktop software; QuickBooks technical support services; financial supplies; and small business payroll products and services.
Jabil Circuit, Inc. (NYSE:JBL), ended its Friday’s trading session with 1.08% gain, and closed at $24.23.
Jabil Circuit, Inc. (JBL) an electronic products solutions company, will announce its third quarter of fiscal year 2015 financials on Wednesday, June 17, 2015 after the market close. The company’s conference call to review the results will be broadcast on at 4:30 p.m. ET live on the Internet at http://www.jabil.com.
Jabil Circuit, Inc., together with its auxiliaries, provides electronic manufacturing services and solutions worldwide. It offers electronics design, production, and product administration services to companies in the aerospace, automotive, computing, defense, digital home, energy, healthcare, industrial, instrumentation, lifestyles, mobility, mold, networking, packaging, peripherals, storage, telecommunications, and wearable technology industries.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
